A few days ago, the US reported the presence of the Brazilin variant of coronavirus in a person who recently traveled back from Brazil. Every day, newer and more mutated coronavirus variants are being spotted in the country, all of which are more contagious and deadlier than the original strain. However, health experts believe that coronavirus vaccines will provide protection against all of these mutated versions of coronavirus. The White House Response team has confirmed that Moderna and Pfizer vaccines are now available for Americans, both of which are more than 90% efficient against coronavirus.
The number of UK mutated coronavirus variants has reached 308 cases reported from different areas of 26 US states confirmed by the U.S. Centers for Disease Control and Prevention. Adding the US, this mutated variant has now reached 47 countries, making it the first among all new variants to reach a maximum number of countries.
On the other side, the Brazilian variant which has been recently confirmed in Minnesota has only been reported in five countries. Another variant that originated from South Africa has been identified in 20 counties but it has not reached the US yet.
All of these new coronavirus mutated variants are more transmissible than the original virus and can cause extreme symptoms in any person who contacted them. The presence of these new variants is increasing the number of COVID-19 patients again adding up to the pandemic-related stress and a burden for healthcare systems.
The only good thing happening is that it appears that Pfizer and Moderna vaccines are helpful against all of these variants. Dr. Anthony Fauci, from the National Institute of Allergy and Infectious Diseases, has also confirmed it.
Only one out of all these variants, the UK mutated variant can act slightly different than others and affect the antibody production of these vaccines. But it is negligible and people who have received vaccinations shouldn’t worry about it.
The South African coronavirus variant which has not seen in the US might be tricky to handle because there are chances that it may not react well to the existing vaccines, according to Dr. Fauci.
The third COVID-19 vaccine by Johnson & Johnson will soon be here as it is currently in its phase three clinical trials. Based on its trials, understanding how these mutated versions are responding to vaccines can be much more clear.
This efficiency would not be tested in the US but in other parts of the world where these mutated coronavirus variants are spreading. CDC is currently working on the genetic sequencing of these new variants being reported in different states and they are also planning to prepare the next dose of already available vaccines to make them efficient against mutations that may show up in the future.
If the virus is mutating, the efforts to develop an effective product against the virus are also increasing. Improving the efficacy of existing vaccines will be completed specifically for the new mutations which are possible as per coronavirus structure.